Format

Send to

Choose Destination
Ann Pharmacother. 2015 Jun;49(6):727-34. doi: 10.1177/1060028015574593. Epub 2015 Feb 27.

Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing.

Author information

1
JFK Medical Center, Atlantis, FL, USA danielwilson938@gmail.com.
2
St Mary's Medical Center, Evansville, IN, USA.
3
Purdue University College of Pharmacy, West Lafayette, IN, USA.

Abstract

OBJECTIVE:

To review the commercially available ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), identify opportunities for therapeutic substitutions within and outside of their Food and Drug Administration (FDA)-approved indications, and identify clinically superior drugs within the class for specific indications.

DATA SOURCE:

A PubMed search (1992 through January 2014) was performed on the terms diclofenac, ketorolac, flurbiprofen, bromfenac, and nepafenac.

STUDY SELECTION AND DATA EXTRACTION:

Clinical trials, meta-analyses, and review articles were evaluated if they were written in English and pertained to human subjects. Studies were excluded if they were in vitro studies, solely evaluated pharmacokinetic or pharmacodynamic properties, did not relate to the topical ophthalmic route, did not evaluate the FDA-approved indications of any available ophthalmic NSAID, or compared a reviewed drug with a nonreviewed drug (without placebo comparison).

DATA SYNTHESIS:

A total of 67 articles met the criteria for evaluation. Article quality, study design, and dosing of the medications were assessed to determine the clinical applicability of the results. The quality of the article was determined using the Oxford Centre for Evidence-based Medicine Levels of Evidence 1.

CONCLUSIONS:

Many formulations of the 5 reviewed NSAIDs have been studied across the 4 primary indications. These indications are (1) pain and inflammation associated with cataract surgery, (2) pain associated with corneal refractive surgery, (3) inhibition of intraoperative miosis, and (4) seasonal allergic conjunctivitis. Several studies have directly compared drugs within this class and have identified instances in which certain selections are therapeutically superior or equivalent to another. This information provides practitioners with guidance in selecting an optimal medication.

KEYWORDS:

Acular; Acuvail; Bromday; Ilevro; NSAID; Nevanac; Ocufen; Prolensa; Voltaren; Xibrom; bromfenac; diclofenac; flurbiprofen; ketorolac; nepafenac; ocular; ophthalmic

PMID:
25725037
DOI:
10.1177/1060028015574593
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center